{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:31:58Z","timestamp":1776810718039,"version":"3.51.2"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hereditary breast and ovarian cancer (HBOC) is an autosomal dominant inherited cancer susceptibility disorder. Both <jats:italic>BRCA1<\/jats:italic> and <jats:italic>BRCA2<\/jats:italic> genes are considered as high penetrance genes of this syndrome. The identification of <jats:italic>BRCA1\/2<\/jats:italic> genetic alterations before cancer development, grant patients the chance to benefit from various medical cancer prevention approaches. Therefore, the appearance of recent advanced technologies in molecular analysis such as next generation sequencing has simplified full <jats:italic>BRCA1\/2<\/jats:italic> analysis.<\/jats:p>\n<jats:p>Many attempts took place in hope of understanding the molecular germline spectrum of these two genes in Moroccan HBOC patients. However, most of the past projects focused only on young breast cancer cases, lacked ovarian cancer cases in their cohort and only a limited number of these studies were able to analyze the entire exons or copy number variations for both genes.<\/jats:p>\n<jats:p>In attempt of gaining more information regarding the molecular profile of <jats:italic>BRCA1\/2<\/jats:italic> in HBOC, we conducted a study in which we analyze their molecular profile on selected Moroccan patients suspected of having HBOC syndrome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In this study we obtained blood samples from 64 selected Moroccan patients, who suffered from Breast and\/or ovarian cancer and had a strong family history for cancer. To analyze <jats:italic>BRCA1\/2<\/jats:italic> punctual variants and copy number variations, we used the Ion Personal Genome Machine (PGM) and Oncomine <jats:italic>BRCA1\/2<\/jats:italic> research assay panel. Afterward, we correlated the molecular results with the clinic-pathologic data using IBM SPSS Statistics ver 2.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>From the 64 selected cases, Forty-six had breast cancer, fifteen had ovarian cancer and three had both breast and ovarian cancer. The molecular analysis revealed that 18 patients from the 64 harbored a pathogenic variant (28%). Twelve had six different <jats:italic>BRCA1<\/jats:italic> pathogenic variants and six had six different <jats:italic>BRCA2<\/jats:italic> pathogenic variants. In this study, we report four pathogenic variants that to the best of our knowledge has never been reported in the Moroccan population before. Regarding copy number variation analysis, No CNV was detected in both genes for all the 64 successfully sequenced and analyzed patients in our cohort.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Work like the present has an important implication on public health and science. It is critical that molecular profiling studies are performed on underserved and understudied population like Morocco.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07250-0","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T17:03:48Z","timestamp":1597079028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Screening of BRCA1\/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-2502","authenticated-orcid":false,"given":"Fatima Zahra","family":"El Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Jouali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Marchoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohcine Mechita","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima Nourouti","family":"Ghailani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Fekkak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"7250_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-005-0696-7","volume":"84","author":"MP Lux","year":"2006","unstructured":"Lux MP, Fasching PA, Beckmann MW. Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med. 2006;84:16\u201328.","journal-title":"J Mol Med"},{"key":"7250_CR2","first-page":"145","volume":"8","author":"MJ Larsen","year":"2014","unstructured":"Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl). 2014;8:145\u201355.","journal-title":"Breast Cancer (Auckl)"},{"key":"7250_CR3","doi-asserted-by":"crossref","unstructured":"Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, Schilder RJ, Cortesi L. Hereditary ovarian cancer: Not only BRCA 1 and 2 Genes. Biomed Res Int.\u00a02015;2015:341723.","DOI":"10.1155\/2015\/341723"},{"issue":"4","key":"7250_CR4","first-page":"644","volume":"133","author":"HT Lynch","year":"1971","unstructured":"Lynch HT, Krush AJ. Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet. 1971;133(4):644\u20138.","journal-title":"Surg Gynecol Obstet"},{"issue":"13","key":"7250_CR5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/jama.1972.03210130023005","volume":"222","author":"HT Lynch","year":"1972","unstructured":"Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH. Tumor variation in families with breast cancer. JAMA. 1972;222(13):1631\u20135.","journal-title":"JAMA."},{"key":"7250_CR6","volume-title":"Clinical practice guidelines in oncology (NCCN guidelines) genetic\/familial high-risk assessment: breast and ovarian","author":"NCCN","year":"2013","unstructured":"NCCN. Clinical practice guidelines in oncology (NCCN guidelines) genetic\/familial high-risk assessment: breast and ovarian. ed 4 ed; 2013. National Comprehensive Cancer Network.","edition":"ed 4"},{"key":"7250_CR7","doi-asserted-by":"crossref","unstructured":"Lynch HT, Snyder C, Casey MJ. Hereditary ovarian and breast cancer: what have we learned?.\u00a0Ann Oncol. 2013;24(Suppl 8):viii83\u201395.\u00a0.","DOI":"10.1093\/annonc\/mdt313"},{"issue":"1","key":"7250_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7150\/ijms.5014","volume":"10","author":"A Laraqui","year":"2013","unstructured":"Laraqui A, Uhrhammer N, Lahlou-Amine I, Rhaffouli HE, Baghdadi JE, Dehayni M, et al. Mutation screening of the BRCA1 gene in early onset and familial breast\/ovarian Cancer in Moroccan population. Int J Med Sci. 2013;10(1):60\u20137.","journal-title":"Int J Med Sci"},{"key":"7250_CR9","doi-asserted-by":"publisher","unstructured":"Padamsee TJ, Wills CE, Yee LD, Paskett ED. Decision making for breast cancer prevention among women at elevated risk. Breast Cancer Res. 2017:19. https:\/\/doi.org\/10.1186\/s13058-017-0826-5.","DOI":"10.1186\/s13058-017-0826-5"},{"issue":"4","key":"7250_CR10","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/cancers11040522","volume":"11","author":"VA Golubeva","year":"2019","unstructured":"Golubeva VA, Nepomuceno TC, Alvaro NA. Monteiro. Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation. Cancers. 2019;11(4):522.","journal-title":"Cancers"},{"key":"7250_CR11","first-page":"828","volume":"57","author":"N Puget","year":"1997","unstructured":"Puget N, Torchard D, Serova-Sinilnikova O, Lynch HT, Feunteun J, Lenoir GM, Mazoyer S. A 1 kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res. 1997;57:828\u201331.","journal-title":"Cancer Res"},{"key":"7250_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejim.2016.03.010","volume":"32","author":"J Azzollini","year":"2016","unstructured":"Azzollini J, Scuvera G, Bruno E, Pasanisi P, Zaffaroni D, Calvello M, et al. Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: a monocentric Italian study. Eur J Intern Med. 2016;32:65\u201371.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"7250_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10689-017-0038-2","volume":"17","author":"GES Felix","year":"2018","unstructured":"Felix GES, Zheng Y, Olopade OI. Mutations in Context: Implications of BRCA testing in diverse populations. Fam Cancer. 2018;17(4):471\u201383.","journal-title":"Fam Cancer"},{"key":"7250_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40246-018-0171-5","volume":"12","author":"FC Cardoso","year":"2018","unstructured":"Cardoso FC, Goncalves S, Mele PG, Liria NC, Sganga L, Perez ID, Podesta EJ, Solano AR. BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population. Hum Genomics. 2018;12:39.","journal-title":"Hum Genomics"},{"key":"7250_CR15","doi-asserted-by":"crossref","unstructured":"Bakkach J, Mansouri M, Derkaoui T, Loudiyi A, Fihri M, Hassani S, et al. Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco. BMC Women's Health. 2017:106;2\u20139.","DOI":"10.1186\/s12905-017-0456-1"},{"key":"7250_CR16","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.3390\/cancers3022382","volume":"3","author":"R Bhikoo","year":"2011","unstructured":"Bhikoo R, Srinivasa S, Yu T-C, Moss D, Hill AG. Systematic review of breast cancer biology in developing countries (part 2): Asian subcontinent and South East Asia. Cancers. 2011;3:2382\u2013401.","journal-title":"Cancers"},{"key":"7250_CR17","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/cancers3022358","volume":"3","author":"R Bhikoo","year":"2011","unstructured":"Bhikoo R, Srinivasa S, Yu T-C, Moss D, Hill AG. Systematic review of breast cancer biology in developing countries (part 1): Africa, the Middle East, Eastern Europe, Mexico, the Caribbean and South America. Cancers. 2011;3:2358\u201381.","journal-title":"Cancers"},{"issue":"3","key":"7250_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ygyno.2012.03.007","volume":"125","author":"A Amal Tazzite","year":"2012","unstructured":"Amal Tazzite A, Hassan Jouhadi B, Sellama Nadifi A, Aretini P, et al. BRCA1 and BRCA2 germline mutations in Moroccan breast\/ovarian cancer families: Novel mutations and unclassified variants. Gynecol Oncol. 2012;125(3):687\u201392 125 (2012) 687\u2013692.","journal-title":"Gynecol Oncol"},{"key":"7250_CR19","doi-asserted-by":"crossref","unstructured":"Laraqui A, Uhrhammer N, Lahlou-Amine I, Rhaffouli HEL, El Baghdadi J, et al. Mutation Screening of the BRCA1 Gene in Early Onset and Familial Breast\/Ovarian Cancer in Moroccan Population. Int J Med Sci.\u00a02013;10(1):60\u20137.\u00a0.","DOI":"10.7150\/ijms.5014"},{"key":"7250_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12885-019-5463-1","volume":"19","author":"K Abdulrashid","year":"2019","unstructured":"Abdulrashid K, AlHussaini N, Ahmed W, Thalib L. Prevalence of BRCA mutations among hereditary breast and\/or ovarian cancer patients in Arab countries: systematic review and meta-analysis. BMC Cancer. 2019;19:256.","journal-title":"BMC Cancer"},{"key":"7250_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-019-0616-z","volume":"11","author":"R Walsh","year":"2019","unstructured":"Walsh R, Mazzarotto F, Whiffin N, Buchan R, Midwinter W, Wilk A, Li N, Felkin L, Ingold N, Govind R, Ahmad M, Mazaika E, Allouba M, Zhang X, de Marvao A, Day SM, Ashley E, Colan SD, Michels M, Pereira AC, Jacoby D, Ho CY, Thomson KL, Watkins H, Barton PJR, Olivotto I, Cook SA, Ware JS. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy. Genome Med. 2019;11:5.","journal-title":"Genome Med"},{"issue":"1","key":"7250_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1897-4287-4-1-7","volume":"4","author":"S Ciernikova","year":"2006","unstructured":"Ciernikova S, Tomka M, Kovac M, Stevurkova V, Zaja V. Age and geographical distribution in families with BRCA1\/BRCA2 mutations in the Slovak Republic. Hered Cancer Clin Pract. 2006;4(1):7\u201311.","journal-title":"Hered Cancer Clin Pract"},{"key":"7250_CR23","doi-asserted-by":"crossref","unstructured":"Alemar B, Gregorio C, Herzog J, Matzenbacher Bittar C, BrinckmannOliveira Netto C, Artigalas O, et al. BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population. PLoS ONE. 2017;13(5).","DOI":"10.1371\/journal.pone.0197529"},{"issue":"7","key":"7250_CR24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","volume":"1","author":"A Desmond","year":"2015","unstructured":"Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N, Ford JM, Lincoln SE, Ellisen LW. Clinical Actionability of multigene panel testing for hereditary breast and ovarian Cancer risk assessment. JAMA Oncol. 2015;1(7):943\u201351.","journal-title":"JAMA Oncol"},{"issue":"1","key":"7250_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ogc.2010.03.003","volume":"37","author":"LP Shulman","year":"2010","unstructured":"Shulman LP. Hereditary Breast and Ovarian Cancer (HBOC): Clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and li-Fraumeni syndrome. Obstet Gynecol Clin North Am. 2010;37(1):109\u201333.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"7250_CR26","first-page":"150","volume":"23","author":"A Tazzite","year":"2013","unstructured":"Tazzite A, Jouhadi H, Saiss K, Benider A, Nadifi S. Relationship between family history of breast Cancer and Clinicopathological features in Moroccan patients. EJHS. 2013;23:150\u20137.","journal-title":"EJHS."},{"key":"7250_CR27","doi-asserted-by":"crossref","unstructured":"Shi T, Pan W, Xie C, Yin S, Shi D, Wei C, Tang W, Jiang R, Cheng X, Wei Q, Wang Q, Zang R. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. Int J Cancer.\u00a02017;140(9):2051\u20139.","DOI":"10.1002\/ijc.30633"},{"key":"7250_CR28","doi-asserted-by":"crossref","unstructured":"Yang X, Wu J, Lu J, Liu G, Di G, Chen C, Hou Y, Sun M, Yang W, Xu X, et al. Identification of a comprehensive Spectrum of genetic factors for hereditary breast Cancer in a Chinese population by next-generation sequencing. PLoS One.\u00a02015;10(4):e0125571.","DOI":"10.1371\/journal.pone.0125571"},{"key":"7250_CR29","doi-asserted-by":"crossref","unstructured":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. Lancet. 1997;349(9064):1505\u201310.","DOI":"10.1016\/S0140-6736(96)10109-4"},{"key":"7250_CR30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1634\/theoncologist.2014-0364","volume":"20","author":"NS El Saghir","year":"2015","unstructured":"El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, Charara RN, et al. BRCA1 and BRCA2 Mutations in Ethnic Lebanese ArabWomenWith High Hereditary Risk Breast Cancer. TheOncologist. 2015;20:357\u201364.","journal-title":"TheOncologist"},{"key":"7250_CR31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/030089160509100611","volume":"91","author":"A Musolino","year":"2005","unstructured":"Musolino A, Michiara M, Bella MA, Naldi N, Zanelli P, Bortesi B, Capelletti M, Soldani L, Camisa R, Martella E, Franciosi V, Savi M, Neri TM, Ardizzoni A, Cascinu S. molecular profile and clinical variables in brca1-positive breast cancers. a population-based study. Tumori. 2005;91:505\u201312.","journal-title":"Tumori"},{"issue":"49","key":"7250_CR32","doi-asserted-by":"crossref","first-page":"80465","DOI":"10.18632\/oncotarget.12610","volume":"7","author":"GC Fernandes","year":"2016","unstructured":"Fernandes GC, Michelli RAD, Galv\u00e3o HCR, Paula AE, Pereira R, Andrade CE, Felicio PS, et al. Prevalence of BRCA1\/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry. Oncotarget. 2016;7(49):80465\u201381.","journal-title":"Oncotarget"},{"key":"7250_CR33","first-page":"2051","volume":"140","author":"T Shi","year":"2017","unstructured":"Shi T, Wang P, Xie C, Yin S, Di Shi CW, Tang W, Jiang R, Chen X, Wei Q, Wang Q, Zang R. BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer. IJC. 2017;140:2051\u20139 V C 2017 UICC.","journal-title":"IJC"},{"issue":"70","key":"7250_CR34","doi-asserted-by":"crossref","first-page":"114463","DOI":"10.18632\/oncotarget.22962","volume":"8","author":"Y Hirotsu","year":"2017","unstructured":"Hirotsu Y, Ooka Y, Sakamoto I. Hiroshi Nakagomi, and Masao Omata; simultaneous detection of genetic and copy number alterations in BRCA1\/2 genes. Oncotarget. 2017;8(70):114463\u201373.","journal-title":"Oncotarget"},{"key":"7250_CR35","doi-asserted-by":"crossref","unstructured":"Cao W-M, Zheng Y-B, Gao Y, Ding X-W, Sun Y, Huang Y, Lou C-J, Pan Z-W, Peng G, Wang X-J. Comprehensive mutation detection of BRCA1\/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.\u00a0BMC Cancer.\u00a02019;19(1):551.","DOI":"10.1186\/s12885-019-5765-3"},{"key":"7250_CR36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ejhg.2016.203","volume":"25","author":"LC Walker","year":"2017","unstructured":"Walker LC, Marquart L, Pearson JF, Wiggins GAR, O'Mara TA, Parsons MT, BCFR DB, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, EMBRACE, Godwin AK, Meindl A, Schmutzler RK, Collaborators GEMOS, Isaacs C, Peshkin BN, Caldes T, Hogervorst FBL, HEBON, Lazaro C, Jakubowska A, Montagna M, KConFab Investigators, Chen X, Offit K, Hulick PJ, Andrulis IL, Lindblom A, Nussbaum RL, Nathanson KL, Chenevix-Trench G, Antoniou AC, Couch FJ, Spurdle AB. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet. 2017;25:432\u20138.","journal-title":"Eur J Hum Genet"},{"key":"7250_CR37","doi-asserted-by":"crossref","unstructured":"Abdelilah Laraqui, Nancy Uhrhammer, Hicham EL Rhaffouli, Yassine Sekhsokh, Idriss Lahlou-Amine, Tahar Bajjou, Farida Hilali, Jamila El Baghdadi; BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African; Hindawi Publishing Corporation Disease Markers Volume 2015, Article ID 194293.","DOI":"10.1155\/2015\/194293"},{"issue":"2","key":"7250_CR38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3892\/ol.2016.4739","volume":"12","author":"F Jouali","year":"2016","unstructured":"Jouali F, Ratbi I, Elalaoui SC, Fekkak, and Abdelaziz Sefiani. First application of next-generation sequencing in Moroccan breast\/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene. Oncol Lett. 2016;12(2):1192\u20136.","journal-title":"Oncol Lett"},{"key":"7250_CR39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3892\/ol.2011.248","volume":"2","author":"FZ Laarabi","year":"2011","unstructured":"Laarabi FZ, Jaouad IC, Ouldim K, Aboussair N, Jalil A, Gueddari BE, Benjaafar N, Sefiani A. Genetic testing and first presymptomatic diagnosis in moroccan families at high risk for breast\/ovarian cancer. Oncol Lett. 2011;2:389\u201393.","journal-title":"Oncol Lett"},{"issue":"7","key":"7250_CR40","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.20340","volume":"27","author":"AH van der Hout","year":"2006","unstructured":"van der Hout AH, van den Ouweland AM, van der Luijt RB, Gille HJ, Bodmer D, Br\u00fcggenwirth H. Mulder IM, et al; a DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting. Hum Mutat. 2006;27(7):654\u201366.","journal-title":"Hum Mutat"},{"key":"7250_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12885-015-1040-4","volume":"15","author":"M El Khachibi","year":"2015","unstructured":"El Khachibi M, Diakite B, Hamzi K, Badou A, Senhaji MA, Bakhchane A, Jouhadi H, Barakat A, Benider A. Nadifi S; screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients. BMC Cancer. 2015;15:81.","journal-title":"BMC Cancer"},{"issue":"8","key":"7250_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136419","volume":"10","author":"CM Strom","year":"2015","unstructured":"Strom CM, Rivera S, Elzinga C, Angeloni T, Rosenthal SH, Goos-Root D, Siaw M, Platt J, Braastadt C, Cheng L, Ross D. Sun W; development and validation of a next-generation sequencing assay for BRCA1 and BRCA2 variants for the clinical laboratory. PLoS One. 2015;10(8):e0136419.","journal-title":"PLoS One"},{"issue":"6","key":"7250_CR43","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2012.31","volume":"106","author":"L Robertson","year":"2012","unstructured":"Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I, Turnbull C, Houlston R, Shanley S, Butler S. D G Evans, G Ross, D Eccles, a Tutt, N Rahman, BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer. 2012;106(6):1234\u20138.","journal-title":"Br J Cancer"},{"issue":"4","key":"7250_CR44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","volume":"8","author":"J Simard","year":"1994","unstructured":"Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, Leblanc JF, B\u00e9langer C, Dion F, et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet. 1994 Dec;8(4):392\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"7250_CR45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius R. Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J. 2010;1(3):397\u2013412.","journal-title":"EPMA J"},{"issue":"4","key":"7250_CR46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/humu.9226","volume":"23","author":"L Foretova","year":"2004","unstructured":"Foretova L, Machackova E, Navratilova M, Pavlu H, Hruba M, Lukesova M. Valik D; BRCA1 and BRCA2 mutations in women with familial or early-onset breast\/ovarian cancer in the Czech Republic. Hum Mutat. 2004 Apr;23(4):397\u20138.","journal-title":"Hum Mutat"},{"issue":"1","key":"7250_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.1320570102","volume":"57","author":"JP Struewing","year":"1995","unstructured":"Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast\/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet. 1995;57(1):1\u20137.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"7250_CR48","first-page":"663","volume":"9","author":"AA Zoure","year":"2018","unstructured":"Zoure AA, Slaoui M, Bambara HA, Sawadogo AY, Compaor\u00e9 TR, Ou\u00e9draogo NLM, El Mzibri M, Attaleb M, Traor\u00e9 SS, Simpore J, Bakri Y. BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso. J Public Health Afr. 2018;9(1):663.","journal-title":"J Public Health Afr"},{"issue":"12","key":"7250_CR49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD. Olopade OI; breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007;7(12):937\u201348.","journal-title":"Nat Rev Cancer"},{"issue":"44","key":"7250_CR50","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, Roeb W, Agnew KJ, Stray SM, Wickramanayake A, Norquist B, Pennington KP, Garcia RL, King M-C, Swisher EM. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A. 2011;108(44):18032\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7250_CR51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10689-017-9985-x","volume":"16","author":"X Gabald\u00f3 Barrios","year":"2017","unstructured":"Gabald\u00f3 Barrios X, Sarabia Meseguer MD, Mar\u00edn Vera M, S\u00e1nchez Berm\u00fadez AI, Mac\u00edas Cerrolaza JA, S\u00e1nchez Henarejos P, Zafra Poves M, Garc\u00eda Hern\u00e1ndez MR, Cuevas Tortosa E, Aliaga Ba\u00f1o \u00c1. Castillo Guardiola V, et al; molecular characterization and clinical interpretation of BRCA1\/BRCA2 variants in families from Murcia (South-Eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Familial Cancer. 2017;16(4):477\u201389.","journal-title":"Familial Cancer"},{"key":"7250_CR52","doi-asserted-by":"crossref","unstructured":"Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals. Breast Cancer Res.\u00a02011;13(1):R20.","DOI":"10.1186\/bcr2832"},{"issue":"3","key":"7250_CR53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ccr3.718","volume":"5","author":"I Antonucci","year":"2017","unstructured":"Antonucci I, Provenzano M, Sorino L, Rodrigues M, Palka G, Stuppia L. A new case of \"de novo\" BRCA1 mutation in a patient with early-onset breast cancer. Clin Case Rep. 2017;5(3):238\u201340.","journal-title":"Clin Case Rep"},{"issue":"11","key":"7250_CR54","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/ejhg.2009.89","volume":"17","author":"V Caux-Moncoutier","year":"2009","unstructured":"Caux-Moncoutier V, Pag\u00e8s-Berhouet S, Michaux D, Asselain B, Cast\u00e9ra L, De Pauw A, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Houdayer C. Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study. Eur J Hum Genet. 2009;17(11):1471\u201380.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"7250_CR55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1155\/2010\/585278","volume":"28","author":"F Cherbal","year":"2010","unstructured":"Cherbal F, Bakour R, Adane S, Boualga K, Benais-Pont G. Maillet P; BRCA1 and BRCA2 germline mutations screening in Algerian breast\/ovarian cancer families. Dis Markers. 2010;28(6):377\u201384.","journal-title":"Dis Markers"},{"issue":"3","key":"7250_CR56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","volume":"12","author":"SV Tavtigian","year":"1996","unstructured":"Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996;12(3):333\u20137.","journal-title":"Nat Genet"},{"issue":"22","key":"7250_CR57","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","volume":"21","author":"DA Levine","year":"2003","unstructured":"Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, Soslow RA, Boyd J. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. JCO. 2003;21(22):4222\u20137.","journal-title":"JCO"},{"issue":"35","key":"7250_CR58","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","volume":"27","author":"MK Graeser","year":"2009","unstructured":"Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. JCO. 2009;27(35):5887\u201392.","journal-title":"JCO"},{"issue":"4","key":"7250_CR59","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/bcr3218","volume":"14","author":"J Lecarpentier","year":"2012","unstructured":"Lecarpentier J, Nogu\u00e8s C, Mouret-Fourme E, Gauthier-Villars M, Lasset C, Fricker JP, Caron O, Stoppa-Lyonnet D. Berthet P, et alVariation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French national BRCA1 and BRCA2 mutations carrier cohort (GENEPSO). Breast Cancer Res. 2012;14(4):R99.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"7250_CR60","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J, Takayama S, Kamata H, Sekiguchi I, Ubukata M, Kodama T, Arai M, Kasumi F, Hirai Y, Ikeda T, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci. 2008;99(10):1967\u201376.","journal-title":"Cancer Sci"},{"issue":"1","key":"7250_CR61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.maturitas.2013.09.012","volume":"77","author":"M-KM Tea","year":"2014","unstructured":"Tea M-KM, Kroiss R, Muhr D, Fuerhauser-Rappaport C, Oefner P, Wagner TM, Singer CF. Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast Cancer. Maturitas. 2014;77(1):68\u201372.","journal-title":"Maturitas"},{"key":"7250_CR62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13053-017-0085-6","volume":"16","author":"C Heramb","year":"2018","unstructured":"Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR, M\u00e6hle L. BRCA1 and BRCA2 Mutation Spectrum - An Update on Mutation Distribution in a Large Cancer Genetics Clinic in Norway. Hered Cancer Clin Pract. 2018;16:3.","journal-title":"Hered Cancer Clin Pract"},{"key":"7250_CR63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fonc.2018.00480","volume":"8","author":"L Caleca","year":"2018","unstructured":"Caleca L, Catucci I, Figlioli G, De Cecco L, Pesaran T, Ward M, Volorio S, Falanga A, Marchetti M, Iascone M, Tondini C, Zambelli A, Azzollini J, Manoukian S, Radice P, Peterlongo P. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction. Front Oncol. 2018;8:480.","journal-title":"Front Oncol"},{"issue":"72","key":"7250_CR64","doi-asserted-by":"crossref","first-page":"33648","DOI":"10.18632\/oncotarget.26000","volume":"9","author":"A Germani","year":"2018","unstructured":"Germani A, Libi F, Maggi S, Stanzani G, Lombardi A, Pellegrini P, Mattei M, De Marchis L. Claudio Amanti, et al; rapid detection of copy number variations and point mutations in BRCA1\/2 genes using a single workflow by ion semiconductor sequencing pipeline. Oncotarget. 2018;9(72):33648\u201355.","journal-title":"Oncotarget"},{"issue":"12","key":"7250_CR65","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Jessica Mandell MS, Lee MK, Ciernikova S, Foretova L, Soucek P, King M-C. Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer. JAMA. 2006;295(12):1379\u201388.","journal-title":"JAMA"},{"key":"7250_CR66","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12885-019-5765-3","volume":"19","author":"W-M Cao","year":"2019","unstructured":"Cao W-M, Zheng Y-B, Gao Y, Ding X-W, Sun Y, Huang Y, Lou C-J, Pan Z-W, Peng G, Wang X-J. Comprehensive mutation detection of BRCA1\/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women. BMC Cancer. 2019;19:551.","journal-title":"BMC Cancer"},{"issue":"20","key":"7250_CR67","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"2","key":"7250_CR68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10549-008-9926-3","volume":"113","author":"MJ Lund","year":"2009","unstructured":"Lund MJ, Trivers KF, Porter PL, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat. 2009;113(2):357\u201370.","journal-title":"Breast Cancer Res Treat"},{"key":"7250_CR69","first-page":"71","volume":"11","author":"S De Silva","year":"2019","unstructured":"De Silva S, Hemamala K, Tennekoon, Hamilton E, Karunanayake. Overview of the genetic basis toward early detection of breast cancer. Breast Cancer. 2019;11:71\u201380 2019:11 71\u201380.","journal-title":"Breast Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07250-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07250-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07250-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:19:44Z","timestamp":1628551184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07250-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7250"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07250-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee for Research of the University Hassan II. All participants gave a written informed consent to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"747"}}